SVB Securities analyst David Risinger maintained a Hold rating on Pfizer (PFE – Research Report) on June 27 and set a price target of $55.00. The company's shares closed last Wednesday at $50.94. According to TipRanks.com, Risinger is a 2-star analyst with an average return of 0.3% and a 33.3% success rate. Risinger covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, Horizon Therapeutics, and Theravance Biopharma. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Pfizer with a $58.64 average price target, representing a 15.6% upside.
https://www.tipranks.com/news/blurbs/pfizer-pfe-receives-a-hold-from-svb-securities?utm_source=advfn.com&utm_medium=referral